News Focus
News Focus
Followers 74
Posts 14221
Boards Moderated 0
Alias Born 06/03/2015

Re: None

Thursday, 03/21/2019 7:04:58 AM

Thursday, March 21, 2019 7:04:58 AM

Post# of 519060
Biogen and Eisai to Discontinue Phase 3 ENGAGE and EMERGE Trials of aducanumab in Alzheimer’s Disease

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News